Wikidata

(Q38383351)

English

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

scientific article published on 19 December 2016

In more languages

Statements

title
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27992268
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27992268%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 March 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38383351&oldid=2077069541"